One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Ronald Mcdaniel Biography and Net Worth

Director of AdaptHealth

Ronald Mcdaniel is the Director of AdaptHealth.

What is Ronald T. Mcdaniel's net worth?: The estimated net worth of Ronald T. Mcdaniel is at least $227,544.85 as of May 26th, 2021. Mcdaniel owns 23,101 shares of AdaptHealth stock worth more than $227,545 as of April 26th. This net worth approximation does not reflect any other assets that Mcdaniel may own. Learn More about Ronald T. Mcdaniel's net worth.
How do I contact Ronald T. Mcdaniel?: The corporate mailing address for Mcdaniel and other AdaptHealth executives is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. AdaptHealth can also be reached via phone at (610) 424-4515 and via email at [email protected]. Learn More on Ronald T. Mcdaniel's contact information.
Has Ronald T. Mcdaniel been buying or selling shares of AdaptHealth?: Ronald T. Mcdaniel has not been actively trading shares of AdaptHealth within the last three months. Learn More on Ronald T. Mcdaniel's trading history.
Who are AdaptHealth's active insiders?: AdaptHealth's insider roster includes Jason Clemens (CFO), Stephen Griggs (CEO), Ronald Mcdaniel (Director), Frank Mullen (CAO), Alan Quasha (Director), Shaw Rietkerk (COO), and Dale Wolf (Director). Learn More on AdaptHealth's active insiders.
Are insiders buying or selling shares of AdaptHealth?: In the last year, AdaptHealth insiders bought shares 1 times. They purchased a total of 720 shares worth more than $10,152.00. In the last year, insiders at the sold shares 5 times. They sold a total of 527,501 shares worth more than $6,709,619.15. The most recent insider tranaction occured on March, 11th when Major Shareholder James E Flynn sold 182,607 shares worth more than $2,012,329.14. Insiders at AdaptHealth own 13.6% of the company. Learn More about insider trades at AdaptHealth.
Information on this page was last updated on 3/11/2024.

Ronald T. Mcdaniel Insider Trading History at AdaptHealth

Ronald T. Mcdaniel Buying and Selling Activity at AdaptHealth

AdaptHealth Company Overview

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $9.85

$9.59

$9.94

50 Day Range

MA: $10.00

$7.10

$11.51

2 Week Range

Now: $9.85

$6.37

$15.37

Volume

250,598 shs

Average Volume

1,072,689 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>